{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T21:11:09Z","timestamp":1786655469279,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To (i) quantify the prevalence of polypharmacy and clinically significant DDIs, (ii) examine their independent and combined associations with ADRs, and (iii) explore whether depression and cognition modify these relationships among older Chinese adults with cancer among older Chinese adults diagnosed with cancer. A total of 408 participants aged \u226560\u00a0years completed both the 2011 baseline and 2013 follow-up surveys, forming the analytic cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This analysis used data from the China Health and Retirement Longitudinal Study (CHARLS; 2011\u20132013). Eligible participants were community-dwelling adults aged \u226560\u00a0years who answered \u201cyes\u201d to the CHARLS question \u201cHas a doctor ever told you that you had a malignant tumour or cancer?\u201d (variable DAOO7-4, mapped to ICD-10 C00\u2013C97). The most frequently reported sites were lung, stomach, colorectal, liver and breast cancers, yielding an analytic cohort of 408 individuals. Polypharmacy (\u22655 medications\/day) was determined through face-to-face interviews, and DDIs were identified using standardized reference compendia. ADRs were confirmed by self-reports corroborated with medical records. Depression and cognition were measured using validated scales. Logistic regression models adjusted for sociodemographic and clinical factors were used to evaluate associations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At baseline, 36.0% of participants reported polypharmacy, rising to 38.0% at follow-up. Clinically significant DDIs increased from 20.1% to 23.0%, while ADRs grew from 6.9% to 8.1%. In adjusted models, both polypharmacy (OR = 2.21, 95% CI = 1.14\u20134.30) and DDIs (OR = 3.28, 95% CI = 1.54\u20136.99) independently heightened ADR risk. Elevated depression scores were also linked to increased odds of ADRs, particularly among older women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Polypharmacy and DDIs substantially magnify the risk of ADRs in older Chinese adults with cancer, with depression further compounding vulnerability. Targeted medication management, careful DDI monitoring, and attention to psychosocial well-being may reduce preventable harms and improve outcomes in this rapidly expanding geriatric oncology population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1579023","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:24:03Z","timestamp":1748496243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Polypharmacy, drug\u2013drug interactions and adverse drug reactions in older Chinese cancer patients: evidence from CHARLS"],"prefix":"10.3389","volume":"16","author":[{"given":"Zijun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-qin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10781552241255140","DOI":"10.1177\/10781552241255140","article-title":"Assessment of polypharmacy, potentially inappropriate medications, and drug-drug interactions in older patients with cancer","volume":"16","author":"Albayrak","year":"2024","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.sapharm.2021.04.018","article-title":"The association between polypharmacy and cognitive ability in older adults: a national cohort study","volume":"18","author":"Aljeaidi","year":"2022","journal-title":"Res. Soc. Adm. Pharm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1186\/s12877-023-04471-3","article-title":"Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with adverse outcomes","volume":"23","author":"Bandidwattanawong","year":"2023","journal-title":"BMC Geriatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jgo.2020.12.007","article-title":"Interventions to reduce polypharmacy and optimize medication use in older adults with cancer","volume":"12","author":"Barlow","year":"2021","journal-title":"J. geriatric Oncol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-030-89162-6_6","volume-title":"Comorbidity and polypharmacy in older adults with cancer and frailty[M]\/\/Frailty in older adults with cancer","author":"Berger","year":"2022"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1257638","DOI":"10.3389\/fcimb.2023.1257638","article-title":"The impact of concurrent bacterial lung infection on immunotherapy in patients with non-small cell lung cancer: a retrospective cohort study","volume":"13","author":"Cao","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1291920","DOI":"10.3389\/fphar.2023.1291920","article-title":"Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review","volume":"14","author":"Cao","year":"","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"9447","DOI":"10.26355\/eurrev_202212_30696","article-title":"Risk factors for the development of hepatocellular carcinoma in Chengdu: a prospective cohort study","volume":"26","author":"Cao","year":"2022","journal-title":"Eur. Rev. Med. and Pharmacol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"745688","DOI":"10.3389\/fphar.2021.745688","article-title":"Predictors of polypharmacy among elderly patients in China: the role of decision involvement, depression, and taking Chinese medicine behavior","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1017\/S1041610213001701","article-title":"Factorial validity of the center for epidemiologic studies depression Scale short form in older population in China","volume":"26","author":"Chen","year":"2014","journal-title":"Int. psychogeriatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/CIA.S351731","article-title":"Association between polypharmacy, anxiety, and depression among Chinese older adults: evidence from the Chinese longitudinal healthy longevity survey","volume":"17","author":"Cheng","year":"2022","journal-title":"Clin. Interventions Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1002\/cncr.34813","article-title":"Association of polypharmacy with all\u2010cause mortality and adverse events among elderly colorectal cancer survivors","volume":"129","author":"Choi","year":"2023","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12875-023-02070-0","article-title":"The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study","volume":"24","author":"Doumat","year":"2023","journal-title":"BMC Prim. Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/0361073X.2020.1846949","article-title":"Polypharmacy, physical and nutritional status, and depression in the elderly: do polypharmacy deserve some credits in these problems?","volume":"47","author":"Eyigor","year":"2021","journal-title":"Exp. aging Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2147\/IJGM.S309783","article-title":"Prevalence and patterns of comorbidity among middle-aged and elderly people in China: a cross-sectional study based on CHARLS data","volume":"14","author":"Fan","year":"2021","journal-title":"Int. J. general Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00228-013-1612-7","article-title":"Checklist for standardized reporting of drug\u2013drug interaction management guidelines","volume":"70","author":"Floor-Schreudering","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.6004\/jnccn.2022.7033","article-title":"Association of polypharmacy and potentially inappropriate medications with frailty among older adults with blood cancers","volume":"20","author":"Hshieh","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"B18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.dmpk.2019.10.006","article-title":"Evaluation of drug\u2013drug interactions in drug metabolism: differences and harmonization in guidance\/guidelines","volume":"35","author":"Iwatsubo","year":"2020","journal-title":"Drug metabolism Pharmacokinet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12877-020-01953-6","article-title":"General practitioners\u2019 deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries","volume":"21","author":"Jungo","year":"2021","journal-title":"BMC Geriatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00520-020-05529-3","article-title":"Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case\u2013control study","volume":"29","author":"Keats","year":"2021","journal-title":"Support. Care Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"743138","DOI":"10.3389\/fpubh.2022.743138","article-title":"Impact of polypharmacy, drug-related problems, and potentially inappropriate medications in geriatric patients and its implications for Bulgaria\u2014narrative review and meta-analysis","volume":"10","author":"Krustev","year":"2022","journal-title":"Front. public health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1007\/s11030-022-10382-z","article-title":"Detection of polypharmacy side effects by integrating multiple data sources and convolutional neural networks","volume":"26","author":"Lakizadeh","year":"2022","journal-title":"Mol. Divers."},{"key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000503004","article-title":"The health and retirement study harmonized cognitive assessment protocol project: study design and methods","volume":"54","author":"Langa","year":"2020","journal-title":"Neuroepidemiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"20420986221100117","DOI":"10.1177\/20420986221100117","article-title":"The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review","volume":"13","author":"Lee","year":"2022","journal-title":"Ther. Adv. drug Saf."},{"key":"B25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00508-020-01750-6","article-title":"Considering additive effects of polypharmacy: analysis of adverse events in geriatric patients in long-term care facilities","volume":"133","author":"Lexow","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12877-023-03768-7","article-title":"Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Geriatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.7150\/jca.95757","article-title":"Identification of crucial genes through WGCNA in the progression of gastric cancer","volume":"15","author":"Liu","year":"2024","journal-title":"J. Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2147\/PPA.S498472","article-title":"The attitudes toward polypharmacy and willingness to deprescribe among patients with multimorbidity in rural areas of Shandong province in China: a cross-sectional study","volume":"18","author":"Liu","year":"2024","journal-title":"Patient Prefer. adherence"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e043557","DOI":"10.1136\/bmjopen-2020-043557","article-title":"Influencing factors and their relationships of risk perception and decision-making behaviour of polypharmacy in patients with chronic diseases: a qualitative descriptive study","volume":"11","author":"Liu","year":"2021","journal-title":"BMJ open"},{"key":"B30","doi-asserted-by":"publisher","first-page":"h1059","DOI":"10.1136\/bmj.h1059","article-title":"Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity","volume":"350","author":"Marengoni","year":"2015","journal-title":"Bmj"},{"key":"B31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.6004\/jnccn.2020.7628","article-title":"Association of polypharmacy and potentially inappropriate medications with physical functional impairments in older adults with cancer","volume":"19","author":"Mohamed","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"B32","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jgo.2021.01.009","article-title":"Research priorities to address polypharmacy in older adults with cancer","volume":"12","author":"Nightingale","year":"2021","journal-title":"J. geriatric Oncol."},{"key":"B33","first-page":"47","volume-title":"International council for harmonisation (ICH) guidelines[M]\/\/Regulatory affairs in the pharmaceutical industry","author":"Ojha","year":"2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","article-title":"Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences","volume":"12","author":"Pazan","year":"2021","journal-title":"Eur. Geriatr. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/oncolo\/oyac053","article-title":"Polypharmacy, potentially inappropriate medications, and drug-drug interactions in vulnerable older adults with advanced cancer initiating cancer treatment","volume":"27","author":"Ramsdale","year":"2022","journal-title":"Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/wps.20996","article-title":"Mental health care for older adults: recent advances and new directions in clinical practice and research","volume":"21","author":"Reynolds","year":"2022","journal-title":"World Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/1389200221666200620210522","article-title":"2020 FDA drug-drug interaction guidance: a comparison analysis and action plan by pharmaceutical industrial scientists","volume":"21","author":"Sudsakorn","year":"2020","journal-title":"Curr. drug Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12877-023-03743-2","article-title":"A combination of Beers and STOPP criteria better detects potentially inappropriate medications use among older hospitalized patients with chronic diseases and polypharmacy: a multicenter cross-sectional study","volume":"23","author":"Tang","year":"2023","journal-title":"BMC Geriatr."},{"key":"B39","doi-asserted-by":"publisher","first-page":"977492","DOI":"10.3389\/fphar.2022.977492","article-title":"Risk prediction model of polypharmacy for community-dwelling elderly patients: an assessment tool for early detection","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1080\/0284186X.2023.2270145","article-title":"Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005\u20132017","volume":"62","author":"Thomsen","year":"2023","journal-title":"Acta Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"992394","DOI":"10.3389\/fphar.2022.992394","article-title":"Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: an interrupted time series analysis, 2016\u20132021","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.21037\/atm-21-4238","article-title":"The prevalence and risk factors of potentially inappropriate medication use in older Chinese inpatients with multimorbidity and polypharmacy: a cross-sectional study","volume":"9","author":"Tian","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/wps.21035","article-title":"The alliance in mental health care: conceptualization, evidence and clinical applications","volume":"22","author":"Wampold","year":"2023","journal-title":"World Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/DHPS.S255893","article-title":"Managing polypharmacy in older adults with cancer across different healthcare settings","volume":"13","author":"Whitman","year":"2021","journal-title":"Drug, Healthc. patient Saf."},{"key":"B45","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1186\/s12877-023-04444-6","article-title":"Psychosocial factors associated with medication burden among community-dwelling older people with multimorbidity","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Geriatr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"68809","DOI":"10.1007\/s11356-023-27053-7","article-title":"Physical activity mitigates the influence of blood cadmium on memory function: a cross-sectional analysis in US elderly population","volume":"30","author":"You","year":"2023","journal-title":"Environ. Sci. Pollut. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1192777","DOI":"10.3389\/fphar.2023.1192777","article-title":"A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"Eur. Geriatr. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1579023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:24:05Z","timestamp":1748496245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1579023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":48,"alternative-id":["10.3389\/fphar.2025.1579023"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1579023","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1579023"}}